Kanghui Pharmaceutical to Earn 151 Million Yuan from Kelavi Buyback-- Shaanxi Kanghui Pharmaceutical will earn 151.2 million yuan after Hubei Kelavi Biopharmaceutical repurchases its shares from the Chinese drugmaker, according to a disclosure on the Shanghai Stock...